New perspectives in improving prognosis after myocardial infarction
Abstract
The results of large, epidemiologic studies and clinical trials, e.g., GISSI-Prevenzione, demonstrate that highly purified omega-3 polyunsaturated fatty acids should be included into secondary prevention among myocardial infarction patients. Their positive clinical effects include: all-cause mortality reduction by 21%, mostly due to sudden death risk reduction by 45%.
About the Author
N. M. Akhmedzhanov
State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development. Moscow
Russian Federation
Russian Federation
References
1. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIPrevenzione trial. Lancet 1999; 353(9177): 447-55.
2. Marchioli R, Barzi F, Bomba E, et al. on behalf of the CISSIPrevenzione investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Circulation 2002; 105: 1897-903.
Review
For citations:
Akhmedzhanov N.M. New perspectives in improving prognosis after myocardial infarction. Cardiovascular Therapy and Prevention. 2006;5(3):95-98. (In Russ.)
Views:
450
Email this article 
